Final state interactions in semi-inclusive neutrino-nucleus scattering: Applications to the T2K and MINERνA experiments

We present a complete comparison of semi-inclusive νμ−12C cross section measurements by T2K and MINERνA collaborations with the predictions from the SuSAv2-MEC model implemented in the neutrino-nucleus event generator GENIE and an unfactorized approach based on the relativistic distorted wave impulse approximation. Results, that include cross sections as function of the final muon and proton kinematics and correlations between both, show that the agreement with data obtained by the relativistic distorted wave impulse approximation approach, that accounts for final-state interactions, matches or improves GENIE-SuSAv2 predictions for very forward angles where scaling violations are relevant.Ministerio de Ciencia e Innovación PID2020–114687-GB-100 and RTI2018-098868-B-I00Junta de Andalucía FQM160, SOMM17/61015/UGR and P20-01247University of Turin BARM-RILO-21Government of Madrid and Complutense University PR65/19–2243

Diagnóstico fenotípico de las inmunodeficiencias primarias en Antioquia, Colombia, 1994-2002.

Recurrent infections are a frequent cause of medical visits. They can be due to a heterogeneous group of dysfunctions that increase the susceptibility to pathogenic and opportunistic microorganisms, such as immunological deficiencies. To define an opportune rational treatment and to guide the molecular diagnosis of primary immunodeficiency diseases, we establish a program for the phenotypic diagnosis of these illnesses in Antioquia, Colombia, including clinical and laboratory evaluations of patients who present recurrent infections with abnormal evolution. Between August 1, 1994 and July 31, 2002, phenotypic diagnosis of primary immunodeficiency was made in 98 patients. Similar to data reported in the literature, antibody deficiencies were the most frequent (40.8%), followed by combined deficiencies (21.4%). This phenotypic characterization has allowed for appropriate treatments for each patient and, in some cases, functional and molecular studies that can lead to a definite molecular diagnosis.La infección recurrente es una causa frecuente de consulta médica y puede deberse a un grupo heterogéneo de trastornos que incrementan la susceptibilidad a los microorganismos patógenos y oportunistas, como las deficiencias inmunológicas subyacentes. Con el fin de definir un tratamiento racional oportuno y orientar el diagnóstico molecular de las inmunodeficiencias primarias, se estableció un programa para el diagnóstico fenotípico de estas enfermedades en el departamento de Antioquia (Colombia), que comprende un análisis clínico y de laboratorio de los individuos que presentan infecciones recurrentes de evolución anormal. Entre el 1 de agosto de 1994 y el 31 de julio de 2002 se hizo el diagnóstico fenotípico de inmunodeficiencia primaria en 98 pacientes. Similar a lo informado en la literatura especializada, en esta región las deficiencias predominantes de anticuerpos fueron las más frecuentes (40,8%) seguidas por las deficiencias combinadas (21,4%). Esta caracterización fenotípica ha permitido iniciar rápidamente el tratamiento adecuado y, en algunos casos, comenzar los estudios funcionales y moleculares que conduzcan al diagnóstico molecular definitivo

Clinical Presentation and Outcomes of Kawasaki Disease in Children from Latin America: A Multicenter Observational Study from the REKAMLATINA Network

Objetivos: Describir la presentación clínica, el manejo y los resultados de la enfermedad de Kawasaki (EK) en Latinoamérica y evaluar los indicadores pronósticos tempranos de aneurisma de la arteria coronaria (AAC). Diseño del estudio: Se realizó un estudio observacional basado en el registro de la EK en 64 centros pediátricos participantes de 19 países latinoamericanos de forma retrospectiva entre el 1 de enero de 2009 y el 31 de diciembre de 2013, y de forma prospectiva desde el 1 de junio de 2014 hasta el 31 de mayo de 2017. Se recopilaron datos demográficos, clínicos y de laboratorio iniciales. Se utilizó una regresión logística que incorporaba factores clínicos y la puntuación z máxima de la arteria coronaria en la presentación inicial (entre 10 días antes y 5 días después de la inmunoglobulina intravenosa [IGIV]) para desarrollar un modelo pronóstico de AAC durante el seguimiento (>5 días después de la IGIV). Resultados: De 1853 pacientes con EK, el ingreso tardío (>10 días tras el inicio de la fiebre) se produjo en el 16%, el 25% tuvo EK incompleta y el 11% fue resistente a la IGIV. Entre los 671 sujetos con puntuación z de la arteria coronaria notificada durante el seguimiento (mediana: 79 días; IQR: 36, 186), el 21% presentaba AAC, incluido un 4% con aneurismas gigantes. Un modelo pronóstico simple que utilizaba sólo una puntuación z de la arteria coronaria máxima ≥2,5 en la presentación inicial fue óptimo para predecir la AAC durante el seguimiento (área bajo la curva: 0,84; IC del 95%: 0,80, 0,88). Conclusiones: De nuestra población latinoamericana, la puntuación z de la arteria coronaria ≥2,5 en la presentación inicial fue el factor pronóstico más importante que precedió a la AAC durante el seguimiento. Estos resultados resaltan la importancia de la ecocardiografía temprana durante la presentación inicial de la EK. © 2023 Los autoresObjectives: To describe the clinical presentation, management, and outcomes of Kawasaki disease (KD) in Latin America and to evaluate early prognostic indicators of coronary artery aneurysm (CAA). Study design: An observational KD registry-based study was conducted in 64 participating pediatric centers across 19 Latin American countries retrospectively between January 1, 2009, and December 31, 2013, and prospectively from June 1, 2014, to May 31, 2017. Demographic and initial clinical and laboratory data were collected. Logistic regression incorporating clinical factors and maximum coronary artery z-score at initial presentation (between 10 days before and 5 days after intravenous immunoglobulin [IVIG]) was used to develop a prognostic model for CAA during follow-up (>5 days after IVIG). Results: Of 1853 patients with KD, delayed admission (>10 days after fever onset) occurred in 16%, 25% had incomplete KD, and 11% were resistant to IVIG. Among 671 subjects with reported coronary artery z-score during follow-up (median: 79 days; IQR: 36, 186), 21% had CAA, including 4% with giant aneurysms. A simple prognostic model utilizing only a maximum coronary artery z-score ≥2.5 at initial presentation was optimal to predict CAA during follow-up (area under the curve: 0.84; 95% CI: 0.80, 0.88). Conclusion: From our Latin American population, coronary artery z-score ≥2.5 at initial presentation was the most important prognostic factor preceding CAA during follow-up. These results highlight the importance of early echocardiography during the initial presentation of KD. © 2023 The Author(s

Measurements of the νμ\nu_{\mu} and νˉμ\bar{\nu}_{\mu}-induced Coherent Charged Pion Production Cross Sections on 12C^{12}C by the T2K experiment

We report an updated measurement of the $\nu_{\mu}$-induced, and the first measurement of the $\bar{\nu}_{\mu}$-induced coherent charged pion production cross section on $^{12}C$ nuclei in the T2K experiment. This is measured in a restricted region of the final-state phase space for which $p_{\mu,\pi} > 0.2$ GeV, $\cos(\theta_{\mu}) > 0.8$ and $\cos(\theta_{\pi}) > 0.6$, and at a mean (anti)neutrino energy of 0.85 GeV using the T2K near detector. The measured $\nu_{\mu}$ CC coherent pion production flux-averaged cross section on $^{12}C$ is $(2.98 \pm 0.37 (stat.) \pm 0.31 (syst.) \substack{ +0.49 \\ -0.00 } \mathrm{ (Q^2\,model)}) \times 10^{-40}~\mathrm{cm}^{2}$. The new measurement of the $\bar{\nu}_{\mu}$-induced cross section on $^{12}{C}$ is $(3.05 \pm 0.71 (stat.) \pm 0.39 (syst.) \substack{ +0.74 \\ -0.00 } \mathrm{(Q^2\,model)}) \times 10^{-40}~\mathrm{cm}^{2}$. The results are compatible with both the NEUT 5.4.0 Berger-Sehgal (2009) and GENIE 2.8.0 Rein-Sehgal (2007) model predictions

A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)

Meeting abstrac

Measurements of the νμ and ν¯μ -induced coherent charged pion production cross sections on C12 by the T2K experiment

We report an updated measurement of the ν μ -induced, and the first measurement of the ¯ ν μ -induced coherent charged pion production cross section on 12 C nuclei in the Tokai-to-Kamioka experiment. This is measured in a restricted region of the final-state phase space for which p μ , π > 0.2     GeV , cos ( θ μ ) > 0.8 and cos ( θ π ) > 0.6 , and at a mean (anti)neutrino energy of 0.85 GeV using the T2K near detector. The measured ν μ charged current coherent pion production flux-averaged cross section on 12 C is ( 2.98 ± 0.37 ( stat ) ± 0.31 ( syst ) + 0.49 − 0.00 ( Q 2   model ) ) × 10 − 40     cm 2 . The new measurement of the ¯ ν μ -induced cross section on 12 C is ( 3.05 ± 0.71 ( stat ) ± 0.39 ( syst ) + 0.74 − 0.00 ( Q 2   model ) ) × 10 − 40     cm 2 . The results are compatible with both the NEUT 5.4.0 Berger-Sehgal (2009) and GENIE 2.8.0 Rein-Sehgal (2007) model predictions

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Papel de los adyuvantes en la modulación de la respuesta inmune

La inmunoprofilaxis es una herramienta valiosa en la prevención de las enfermedades infecciosas; ésta depende de la capacidad del sistema inmune para reconocer y desencadenar una respuesta efectora y de memoria ante los estímulos antigénicos usados como vacunas. Actualmente, existe la necesidad de desarrollar y mejorar las vacunas no replicativas ya existentes de manera que modulen e incrementen la efectividad de la respuesta inmune. Los adyuvantes constituyen una opción en el mejoramiento de este tipo de vacunas ya que incorporados en la formulación de éstas aumentan, aceleran o prolongan la calidad de la respuesta inmune a antígenos específicos. Los adyuvantes pueden ser clasificados de acuerdo a su mecanismo de acción en dos tipos: inmunoestimuladores y sistemas de liberación. Los adyuvantes inmunoestimuladores son derivados de patógenos (lipopolisacáridos, CpG) y su función es activar las células del sistema inmune innato. En contraste, los sistemas de liberación son partículas (emulsiones, micropartículas, ISCOMs) encargadas de entregar el antígeno asociado a una célula presentadora de antígeno. El descubrimiento y desarrollo de nuevos adyuvantes abre la posibilidad de implementar en un futuro vacunas terapéuticas y profilácticas contra el cáncer y enfermedades infecciosas agudas y crónicas que sean más eficaces y seguras para ser utilizadas en humanos y especies animales de importancia económica

Towards Dynamically Adaptive Replicated Databases

In the last few years it has been advocated the need for systems that adapt automatically to changes in their environment. These changes can range from modifications of the load, kind of workload, available resources, network conditions, the kind of clients making requests, server failures and recoveries, etc. Dynamically adaptive systems, also termed autonomic systems, are systems that sense their environment and configure themselves to accommodate changes in their surrounding context in order to maximize one or more performance metrics. Databases are essential components of todays information systems and therefore, they are one of the targets to introduce adaptation. In this paper, we explore how dynamic adaptation is being approached in Middle-R, a database replication middleware. We explore dynamic adaptation for replicated databases in the context of failures, recoveries, workload variations and changes in the available resources